BEVALTIA

Serial Number 97758949
Registration 7202066
700

Registration Progress

Application Filed
Jan 18, 2023
Under Examination
Approved for Publication
Aug 8, 2023
Published for Opposition
Aug 8, 2023
Registered
Oct 24, 2023

Trademark Image

BEVALTIA

Basic Information

Serial Number
97758949
Registration Number
7202066
Filing Date
January 18, 2023
Registration Date
October 24, 2023
Published for Opposition
August 8, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 24, 2023
Registration
Registered
Classes
005

Rights Holder

PRIOVANT THERAPEUTICS, INC.

03
Address
151 W. 42ND STREET
15TH FLOOR
NEW YORK, NY 10036

Ownership History

Roivant Sciences GmbH

Original Applicant
99
Basel CH

Roivant Sciences GmbH

Owner at Publication
99
Basel CH

Roivant Sciences GmbH

Original Registrant
99
Basel CH

PRIOVANT THERAPEUTICS, INC.

New Owner After Registration #1
03
NEW YORK, NY

Legal Representation

Attorney
Lisa L. Mueller

USPTO Deadlines

Next Deadline
1553 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-10-24)
Due Date
October 24, 2029
Grace Period Ends
April 24, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

20 events
Date Code Type Description Documents
May 1, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 1, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 1, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 1, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 1, 2024 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Oct 24, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 24, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 8, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 8, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 19, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 6, 2023 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Jun 30, 2023 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Jun 29, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 29, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 29, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 29, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 29, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 31, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 24, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 21, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations to treat Crohn's Disease for human use; biologic preparations for medical and therapeutic purposes to treat Chron's disease, inflammatory diseases and disorders, diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis; pharmaceutical preparations to treat inflammatory diseases and disorders and diseases and disorders of the immune system; pharmaceutical preparations to treat dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis

Classification

International Classes
005